Conditions:  Recurrent Endometrial Carcinoma;  Recurrent Endometrial Endometrioid Adenocarcinoma;  Refractory Endometrial Carcinoma;  Refractory Endometrial Endometrioid Adenocarcinoma;  Stage III Uterine Corpus Cancer AJCC v8;  Stage IIIA Uterine Corpus Cancer AJCC v8;  Stage IIIB Uterine Corpus Cancer AJCC v8;  Stage IIIC Uterine Corpus Cancer AJCC v8;  Stage IIIC1 Uterine Corpus Cancer AJCC v8;  Stage IIIC2 Uterine Corpus Cancer AJCC v8;  Stage IV Uterine Corpus Cancer AJCC v8;  Stage IVA Uterine Corpus Cancer AJCC v8;  Stage IVB Uterine Corpus Cancer AJCC v8
Interventions: Â Drug:Â Everolimus; Â Drug:Â Letrozole; Â Drug:Â Ribociclib
Sponsor:  M.D. Anderson Cancer Center
**RECRUITING NOW**
Interventions: Â Drug:Â Everolimus; Â Drug:Â Letrozole; Â Drug:Â Ribociclib
Sponsor:  M.D. Anderson Cancer Center
**RECRUITING NOW**
Source: View full study details on ClinicalTrials.gov
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.